Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells.
Melo Garcia L, Gangadharan A, Banerjee P, Li Y, Zeng AGX, Rafei H, Lin P, Kumar B, Acharya S, Daher M, Muniz-Feliciano L, Deyter GM, Dominguez G, Park JM, Reyes Silva F, Nunez Cortes AK, Basar R, Uprety N, Shanley M, Kaplan M, Liu E, Shpall EJ, Rezvani K.
Melo Garcia L, et al. Among authors: li y.
Cell Rep. 2025 Jan 3;44(1):115122. doi: 10.1016/j.celrep.2024.115122. Online ahead of print.
Cell Rep. 2025.
PMID: 39754720